These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9345110)

  • 1. Loss of heterozygosity or: how I learned to stop worrying and love mitotic recombination.
    Tischfield JA
    Am J Hum Genet; 1997 Nov; 61(5):995-9. PubMed ID: 9345110
    [No Abstract]   [Full Text] [Related]  

  • 2. Mitotic maneuvers in the light.
    Vrieling H
    Nat Genet; 2001 Jun; 28(2):101-2. PubMed ID: 11381245
    [No Abstract]   [Full Text] [Related]  

  • 3. Induced mitotic recombination of p53 in vivo.
    Wang W; Warren M; Bradley A
    Proc Natl Acad Sci U S A; 2007 Mar; 104(11):4501-5. PubMed ID: 17360553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitotic recombination is suppressed by chromosomal divergence in hybrids of distantly related mouse strains.
    Shao C; Stambrook PJ; Tischfield JA
    Nat Genet; 2001 Jun; 28(2):169-72. PubMed ID: 11381266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Genetic predisposition to cancer in children].
    Brugieres L
    Rev Prat; 2007 May; 57(10):1065-7. PubMed ID: 17899678
    [No Abstract]   [Full Text] [Related]  

  • 6. Familial cancer syndromes and genetic counseling.
    Tomlinson GE
    Cancer Treat Res; 1997; 92():63-97. PubMed ID: 9494758
    [No Abstract]   [Full Text] [Related]  

  • 7. Somatic recombination redux.
    Tischfield JA; Shao C
    Nat Genet; 2003 Jan; 33(1):5-6. PubMed ID: 12509771
    [No Abstract]   [Full Text] [Related]  

  • 8. The molecular genetic basis of childhood neoplasia.
    Mott MG
    Clin Oncol (R Coll Radiol); 1995; 7(5):279-86. PubMed ID: 8580052
    [No Abstract]   [Full Text] [Related]  

  • 9. Genetic epidemiology of childhood cancer.
    Narod SA
    Biochim Biophys Acta; 1996 Dec; 1288(3):F141-50. PubMed ID: 9011177
    [No Abstract]   [Full Text] [Related]  

  • 10. Mitotic recombination map of 13cen-13q14 derived from an investigation of loss of heterozygosity in retinoblastomas.
    Hagstrom SA; Dryja TP
    Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2952-7. PubMed ID: 10077618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Embryonic stem cells and somatic cells differ in mutation frequency and type.
    Cervantes RB; Stringer JR; Shao C; Tischfield JA; Stambrook PJ
    Proc Natl Acad Sci U S A; 2002 Mar; 99(6):3586-90. PubMed ID: 11891338
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rates of loss of heterozygosity and mitotic recombination in NF2 schwannomas, sporadic vestibular schwannomas and schwannomatosis schwannomas.
    Hadfield KD; Smith MJ; Urquhart JE; Wallace AJ; Bowers NL; King AT; Rutherford SA; Trump D; Newman WG; Evans DG
    Oncogene; 2010 Nov; 29(47):6216-21. PubMed ID: 20729918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High frequency in vivo loss of heterozygosity is primarily a consequence of mitotic recombination.
    Gupta PK; Sahota A; Boyadjiev SA; Bye S; Shao C; O'Neill JP; Hunter TC; Albertini RJ; Stambrook PJ; Tischfield JA
    Cancer Res; 1997 Mar; 57(6):1188-93. PubMed ID: 9067291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of heterozygosity occurs via mitotic recombination in Trp53+/- mice and associates with mammary tumor susceptibility of the BALB/c strain.
    Blackburn AC; McLary SC; Naeem R; Luszcz J; Stockton DW; Donehower LA; Mohammed M; Mailhes JB; Soferr T; Naber SP; Otis CN; Jerry DJ
    Cancer Res; 2004 Aug; 64(15):5140-7. PubMed ID: 15289317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of gene targeting to study recombination in mammalian cell DNA repair mutants.
    Nairn RS; Adair GM
    Methods Mol Biol; 2006; 314():133-54. PubMed ID: 16673880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A child with Li-Fraumeni syndrome: Modes to inactivate the second allele of TP53 in three different malignancies.
    Schlegelberger B; Kreipe H; Lehmann U; Steinemann D; Ripperger T; Göhring G; Thomay K; Rump A; Di Donato N; Suttorp M
    Pediatr Blood Cancer; 2015 Aug; 62(8):1481-4. PubMed ID: 25787918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel TP53 splicing mutation in a Li-Fraumeni syndrome family: a patient with Wilms' tumour is not a mutation carrier.
    Varley JM; McGown G; Thorncroft M; White GR; Tricker KJ; Kelsey AM; Birch JM; Evans DG
    Br J Cancer; 1998 Oct; 78(8):1081-3. PubMed ID: 9792154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic alterations associated with loss of heterozygosity for TP53 in Li-Fraumeni syndrome fibroblasts.
    Burt EC; James LA; Greaves MJ; Birch JM; Boyle JM; Varley JM
    Br J Cancer; 2000 Aug; 83(4):467-72. PubMed ID: 10945493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitotic recombination produces the majority of recessive fibroblast variants in heterozygous mice.
    Shao C; Deng L; Henegariu O; Liang L; Raikwar N; Sahota A; Stambrook PJ; Tischfield JA
    Proc Natl Acad Sci U S A; 1999 Aug; 96(16):9230-5. PubMed ID: 10430925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of gene targeting to study recombination in mammalian DNA repair mutants.
    Nairn RS; Adair GM
    Methods Mol Biol; 1999; 113():499-517. PubMed ID: 10443446
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.